GLP-1 Weight-Loss Drug Slows Biological Aging Markers in HIV Patients, Study Finds

1 min read
Source: SciTechDaily
GLP-1 Weight-Loss Drug Slows Biological Aging Markers in HIV Patients, Study Finds
Photo: SciTechDaily
TL;DR

In a randomized trial of 108 adults with HIV-associated lipohypertrophy, semaglutide slowed several epigenetic aging clocks—9% on DunedinPACE and reduced PCGrimAge–related aging risk—suggesting GLP-1 drugs may influence aging biology beyond weight loss, though larger studies are needed.

Share this article

Want the full story? Read the original reporting

Read on SciTechDaily